Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

Clinical & Experimental Metastasis, Jan 2019

Shiue-Wei Lai, Oluwaseun Adebayo Bamodu, Wen-Chiuan Tsai, Yi-Ming Chang, Wei-Hwa Lee, Chi-Tai Yeh, Tsu-Yi Chao

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs10585-018-9949-z.pdf

Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

Clinical & Experimental Metastasis pp 1–1 | Cite as Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity AuthorsAuthors and affiliations Shiue-Wei LaiOluwaseun Adebayo BamoduWen-Chiuan TsaiYi-Ming ChangWei-Hwa LeeChi-Tai YehTsu-Yi Chao Correction First Online: 04 January 2019 133 Downloads The original article can be found online at  https://doi.org/10.1007/s10585-018-9919-5. Correction to: Clinical & Experimental Metastasis (2018) 35:663–677  https://doi.org/10.1007/s10585-018-9919-5 In the original publication, the affiliations of authors were published incorrectly. The corrected affiliations are given in this Correction. Copyright information © Springer Nature B.V. 2019 Authors and Affiliations Shiue-Wei Lai123Oluwaseun Adebayo Bamodu45Wen-Chiuan Tsai67Yi-Ming Chang67Wei-Hwa Lee58Chi-Tai Yeh91011Email authorView author's OrcID profileTsu-Yi Chao121314Email author1.Graduate Institute of Clinical Medicine, College of MedicineTaipei Medical UniversityTaipeiTaiwan2.Division of Hematology-Oncology, Department of Internal Medicine, Tri-Service General HospitalNational Defense Medical CenterTaipeiTaiwan3.Department of Internal MedicineTri-Service General Hospital Penghu BranchPenghuTaiwan4.Department of Hematology and Oncology, Cancer CenterTaipei Medical University-Shuang Ho HospitalNew Taipei CityTaiwan5.Department of Medical Research and EducationTaipei Medical University-Shuang Ho HospitalNew Taipei CityTaiwan6.Department of Pathology, Tri-Service General HospitalNational Defense Medical CenterTaipeiTaiwan7.Graduate Institute of Medical SciencesNational Defense Medical CenterTaipeiTaiwan8.Department of PathologyTaipei Medical University-Shuang Ho HospitalNew Taipei CityTaiwan9.Graduate Institute of Clinical MedicineTaipei Medical UniversityTaipeiTaiwan10.Department of Hematology and Oncology, Cancer CenterTaipei Medical University-Shuang Ho HospitalNew Taipei CityTaiwan11.Department of Medical Research and EducationTaipei Medical University-Shuang Ho HospitalNew Taipei CityTaiwan12.Graduate Institute of Clinical MedicineTaipei Medical UniversityTaipeiTaiwan13.Department of Hematology and Oncology, Cancer CenterTaipei Medical University-Shuang Ho HospitalNew Taipei CityTaiwan14.Department of Medical Research and EducationTaipei Medical University-Shuang Ho HospitalNew Taipei CityTaiwan


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs10585-018-9949-z.pdf

Shiue-Wei Lai, Oluwaseun Adebayo Bamodu, Wen-Chiuan Tsai, Yi-Ming Chang, Wei-Hwa Lee, Chi-Tai Yeh, Tsu-Yi Chao. Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity, Clinical & Experimental Metastasis, 2019, 1-1, DOI: 10.1007/s10585-018-9949-z